Alicia Napoli

Director, Regulatory & Quality Assurance at BacterioScan Inc.

Alicia Napoli has a diverse work experience spanning several companies and roles. Alicia began their career as a QA Supervisor at Baxter in 1975 and stayed with the company until 1981. Alicia then joined Mallinckrodt Pharmaceuticals as a Sr. Director, where they worked for 15 years until 2008. From 2000 to 2008, they served as the Sr. Director Clinical & Regulatory Affairs at Covidien, leading a team responsible for global regulatory strategies and new product development. Alicia then joined Wright Medical Technology as the VP Clinical & Regulatory Affairs, managing a team of 42 professionals and overseeing the development of global clinical and regulatory plans. After leaving Wright Medical Technology in 2011, Alicia worked as a Clinical Research and Regulatory Affairs Professional for various organizations, including MAKO Surgical Corporation and Biedermann Motech GmbH. Alicia also had a brief consultancy role at Biomimedica in 2012. In 2013, Alicia became the Vice President of Quality Management at Biomedical Systems, where they were responsible for overall management of the Quality Management department. Lastly, they retired in 2016 after working for their own company, Home. Throughout their career, Alicia has demonstrated expertise in regulatory affairs, quality management, clinical development, and strategic planning.

Alicia Napoli attended Mississippi University for Women from 1971 to 1975, where they received a Bachelor of Science degree in Microbiology. The information regarding Alicia's education after their time at Mississippi University for Women is not provided.

Location

Chesterfield, United States

Links

Previous companies


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices


BacterioScan Inc.

BacterioScan is a precision bench-top system that enables rapid detection and real-time quantification of microbial growth. It eliminates workflow bottlenecks and the inherent inaccuracies of legacy plating procedures. Its technology is helping clinicians personalize medicine for patients, and it’s helping researchers bring new antibiotics tomarket faster and more economically. The potential applications are far-ranging, offering considerable advantages for any microbiology laboratory that can benefit from rapid detection and real-time quantification of bacterial growth, as well as BacterioScan’s space-saving bench-top footprint and its rapid return on investment.


Employees

11-50

Links